nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0568	0.282	CbGbCtD
Orlistat—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0383	0.19	CbGbCtD
Orlistat—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0366	0.182	CbGbCtD
Orlistat—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0326	0.162	CbGbCtD
Orlistat—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0191	0.0949	CbGbCtD
Orlistat—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0181	0.0897	CbGbCtD
Orlistat—DAGLB—bronchus—chronic obstructive pulmonary disease	0.0148	0.0832	CbGeAlD
Orlistat—PLA2G7—connective tissue—chronic obstructive pulmonary disease	0.0128	0.0719	CbGeAlD
Orlistat—PNLIP—respiratory system—chronic obstructive pulmonary disease	0.0128	0.0718	CbGeAlD
Orlistat—PNLIP—connective tissue—chronic obstructive pulmonary disease	0.0113	0.0632	CbGeAlD
Orlistat—ABHD16A—bronchus—chronic obstructive pulmonary disease	0.0112	0.063	CbGeAlD
Orlistat—ABHD12—bronchus—chronic obstructive pulmonary disease	0.0105	0.0591	CbGeAlD
Orlistat—ABHD16A—trachea—chronic obstructive pulmonary disease	0.0101	0.0566	CbGeAlD
Orlistat—DAGLB—lung—chronic obstructive pulmonary disease	0.00956	0.0537	CbGeAlD
Orlistat—ABHD12—trachea—chronic obstructive pulmonary disease	0.00945	0.053	CbGeAlD
Orlistat—FASN—bronchus—chronic obstructive pulmonary disease	0.00883	0.0496	CbGeAlD
Orlistat—FASN—trachea—chronic obstructive pulmonary disease	0.00793	0.0445	CbGeAlD
Orlistat—PLA2G7—lung—chronic obstructive pulmonary disease	0.00772	0.0433	CbGeAlD
Orlistat—ABHD16A—lung—chronic obstructive pulmonary disease	0.00724	0.0407	CbGeAlD
Orlistat—ABHD12—lung—chronic obstructive pulmonary disease	0.00679	0.0381	CbGeAlD
Orlistat—PNLIP—lung—chronic obstructive pulmonary disease	0.00679	0.0381	CbGeAlD
Orlistat—FASN—lung—chronic obstructive pulmonary disease	0.0057	0.032	CbGeAlD
Orlistat—PLA2G4A—respiratory system—chronic obstructive pulmonary disease	0.00516	0.029	CbGeAlD
Orlistat—PLA2G4A—connective tissue—chronic obstructive pulmonary disease	0.00454	0.0255	CbGeAlD
Orlistat—PLA2G4A—bronchus—chronic obstructive pulmonary disease	0.00424	0.0238	CbGeAlD
Orlistat—PLA2G4A—smooth muscle tissue—chronic obstructive pulmonary disease	0.00415	0.0233	CbGeAlD
Orlistat—PLA2G4A—trachea—chronic obstructive pulmonary disease	0.00381	0.0214	CbGeAlD
Orlistat—PLA2G4A—lung—chronic obstructive pulmonary disease	0.00274	0.0154	CbGeAlD
Orlistat—PLA2G4A—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.000961	0.253	CbGdCrCtD
Orlistat—PLA2G4A—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.000961	0.253	CbGdCrCtD
Orlistat—PLA2G4A—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.000938	0.247	CbGdCrCtD
Orlistat—PLA2G4A—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.000938	0.247	CbGdCrCtD
Orlistat—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000723	0.00175	CcSEcCtD
Orlistat—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.000721	0.00174	CcSEcCtD
Orlistat—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000718	0.00173	CcSEcCtD
Orlistat—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000714	0.00172	CcSEcCtD
Orlistat—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000709	0.00171	CcSEcCtD
Orlistat—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000709	0.00171	CcSEcCtD
Orlistat—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000704	0.0017	CcSEcCtD
Orlistat—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000703	0.0017	CcSEcCtD
Orlistat—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.0007	0.00169	CcSEcCtD
Orlistat—Cough—Formoterol—chronic obstructive pulmonary disease	0.0007	0.00169	CcSEcCtD
Orlistat—Cough—Arformoterol—chronic obstructive pulmonary disease	0.0007	0.00169	CcSEcCtD
Orlistat—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000694	0.00168	CcSEcCtD
Orlistat—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000692	0.00167	CcSEcCtD
Orlistat—Cough—Montelukast—chronic obstructive pulmonary disease	0.000686	0.00166	CcSEcCtD
Orlistat—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000683	0.00165	CcSEcCtD
Orlistat—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000683	0.00165	CcSEcCtD
Orlistat—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000683	0.00165	CcSEcCtD
Orlistat—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000683	0.00165	CcSEcCtD
Orlistat—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000683	0.00165	CcSEcCtD
Orlistat—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000683	0.00165	CcSEcCtD
Orlistat—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000681	0.00164	CcSEcCtD
Orlistat—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000681	0.00164	CcSEcCtD
Orlistat—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000681	0.00164	CcSEcCtD
Orlistat—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000681	0.00164	CcSEcCtD
Orlistat—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00068	0.00164	CcSEcCtD
Orlistat—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00068	0.00164	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000678	0.00164	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000678	0.00164	CcSEcCtD
Orlistat—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000675	0.00163	CcSEcCtD
Orlistat—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000675	0.00163	CcSEcCtD
Orlistat—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000669	0.00162	CcSEcCtD
Orlistat—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000669	0.00161	CcSEcCtD
Orlistat—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000668	0.00161	CcSEcCtD
Orlistat—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000668	0.00161	CcSEcCtD
Orlistat—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000667	0.00161	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000664	0.0016	CcSEcCtD
Orlistat—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000663	0.0016	CcSEcCtD
Orlistat—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000661	0.0016	CcSEcCtD
Orlistat—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000661	0.0016	CcSEcCtD
Orlistat—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000655	0.00158	CcSEcCtD
Orlistat—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000655	0.00158	CcSEcCtD
Orlistat—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000655	0.00158	CcSEcCtD
Orlistat—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000655	0.00158	CcSEcCtD
Orlistat—Infection—Formoterol—chronic obstructive pulmonary disease	0.00065	0.00157	CcSEcCtD
Orlistat—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00065	0.00157	CcSEcCtD
Orlistat—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000645	0.00156	CcSEcCtD
Orlistat—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000645	0.00156	CcSEcCtD
Orlistat—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000645	0.00156	CcSEcCtD
Orlistat—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000643	0.00155	CcSEcCtD
Orlistat—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000642	0.00155	CcSEcCtD
Orlistat—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000642	0.00155	CcSEcCtD
Orlistat—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000641	0.00155	CcSEcCtD
Orlistat—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000641	0.00155	CcSEcCtD
Orlistat—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000641	0.00155	CcSEcCtD
Orlistat—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000637	0.00154	CcSEcCtD
Orlistat—Infection—Montelukast—chronic obstructive pulmonary disease	0.000637	0.00154	CcSEcCtD
Orlistat—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000636	0.00154	CcSEcCtD
Orlistat—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000636	0.00154	CcSEcCtD
Orlistat—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000634	0.00153	CcSEcCtD
Orlistat—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000631	0.00152	CcSEcCtD
Orlistat—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000629	0.00152	CcSEcCtD
Orlistat—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000628	0.00152	CcSEcCtD
Orlistat—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000623	0.0015	CcSEcCtD
Orlistat—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000618	0.00149	CcSEcCtD
Orlistat—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000618	0.00149	CcSEcCtD
Orlistat—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000614	0.00148	CcSEcCtD
Orlistat—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000611	0.00148	CcSEcCtD
Orlistat—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000609	0.00147	CcSEcCtD
Orlistat—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000607	0.00147	CcSEcCtD
Orlistat—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000606	0.00146	CcSEcCtD
Orlistat—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000603	0.00146	CcSEcCtD
Orlistat—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000601	0.00145	CcSEcCtD
Orlistat—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000598	0.00144	CcSEcCtD
Orlistat—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000598	0.00144	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000597	0.00144	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000597	0.00144	CcSEcCtD
Orlistat—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000592	0.00143	CcSEcCtD
Orlistat—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000592	0.00143	CcSEcCtD
Orlistat—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000589	0.00142	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000584	0.00141	CcSEcCtD
Orlistat—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00058	0.0014	CcSEcCtD
Orlistat—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000576	0.00139	CcSEcCtD
Orlistat—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000576	0.00139	CcSEcCtD
Orlistat—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000576	0.00139	CcSEcCtD
Orlistat—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000574	0.00139	CcSEcCtD
Orlistat—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000569	0.00137	CcSEcCtD
Orlistat—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000565	0.00136	CcSEcCtD
Orlistat—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000565	0.00136	CcSEcCtD
Orlistat—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000565	0.00136	CcSEcCtD
Orlistat—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000565	0.00136	CcSEcCtD
Orlistat—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000565	0.00136	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000563	0.00136	CcSEcCtD
Orlistat—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00056	0.00135	CcSEcCtD
Orlistat—Pain—Formoterol—chronic obstructive pulmonary disease	0.00056	0.00135	CcSEcCtD
Orlistat—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000559	0.00135	CcSEcCtD
Orlistat—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000558	0.00135	CcSEcCtD
Orlistat—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000555	0.00134	CcSEcCtD
Orlistat—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000554	0.00134	CcSEcCtD
Orlistat—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000553	0.00133	CcSEcCtD
Orlistat—Pain—Montelukast—chronic obstructive pulmonary disease	0.000548	0.00132	CcSEcCtD
Orlistat—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000547	0.00132	CcSEcCtD
Orlistat—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000545	0.00132	CcSEcCtD
Orlistat—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000544	0.00131	CcSEcCtD
Orlistat—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000542	0.00131	CcSEcCtD
Orlistat—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000542	0.00131	CcSEcCtD
Orlistat—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00054	0.0013	CcSEcCtD
Orlistat—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00054	0.0013	CcSEcCtD
Orlistat—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000539	0.0013	CcSEcCtD
Orlistat—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000537	0.0013	CcSEcCtD
Orlistat—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000537	0.0013	CcSEcCtD
Orlistat—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000535	0.00129	CcSEcCtD
Orlistat—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000535	0.00129	CcSEcCtD
Orlistat—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000534	0.00129	CcSEcCtD
Orlistat—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000533	0.00129	CcSEcCtD
Orlistat—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000529	0.00128	CcSEcCtD
Orlistat—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000524	0.00127	CcSEcCtD
Orlistat—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000524	0.00127	CcSEcCtD
Orlistat—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00052	0.00126	CcSEcCtD
Orlistat—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00052	0.00126	CcSEcCtD
Orlistat—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000518	0.00125	CcSEcCtD
Orlistat—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000518	0.00125	CcSEcCtD
Orlistat—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000518	0.00125	CcSEcCtD
Orlistat—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000518	0.00125	CcSEcCtD
Orlistat—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000516	0.00125	CcSEcCtD
Orlistat—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000512	0.00123	CcSEcCtD
Orlistat—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000511	0.00123	CcSEcCtD
Orlistat—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000511	0.00123	CcSEcCtD
Orlistat—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000509	0.00123	CcSEcCtD
Orlistat—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000509	0.00123	CcSEcCtD
Orlistat—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000508	0.00123	CcSEcCtD
Orlistat—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000507	0.00122	CcSEcCtD
Orlistat—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000507	0.00122	CcSEcCtD
Orlistat—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000506	0.00122	CcSEcCtD
Orlistat—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000502	0.00121	CcSEcCtD
Orlistat—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000499	0.0012	CcSEcCtD
Orlistat—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000491	0.00119	CcSEcCtD
Orlistat—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000489	0.00118	CcSEcCtD
Orlistat—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000489	0.00118	CcSEcCtD
Orlistat—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000482	0.00116	CcSEcCtD
Orlistat—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000482	0.00116	CcSEcCtD
Orlistat—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000482	0.00116	CcSEcCtD
Orlistat—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000481	0.00116	CcSEcCtD
Orlistat—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000477	0.00115	CcSEcCtD
Orlistat—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000473	0.00114	CcSEcCtD
Orlistat—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00047	0.00113	CcSEcCtD
Orlistat—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00047	0.00113	CcSEcCtD
Orlistat—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000463	0.00112	CcSEcCtD
Orlistat—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000463	0.00112	CcSEcCtD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000463	0.00229	CbGpPWpGaD
Orlistat—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00046	0.00111	CcSEcCtD
Orlistat—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000456	0.0011	CcSEcCtD
Orlistat—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000456	0.0011	CcSEcCtD
Orlistat—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000454	0.0011	CcSEcCtD
Orlistat—DAGLA—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000449	0.00222	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000449	0.00222	CbGpPWpGaD
Orlistat—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000448	0.00108	CcSEcCtD
Orlistat—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000448	0.00108	CcSEcCtD
Orlistat—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000444	0.00107	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000444	0.0022	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000444	0.0022	CbGpPWpGaD
Orlistat—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000444	0.00107	CcSEcCtD
Orlistat—FASN—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000442	0.00219	CbGpPWpGaD
Orlistat—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000441	0.00107	CcSEcCtD
Orlistat—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000439	0.00106	CcSEcCtD
Orlistat—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000437	0.00106	CcSEcCtD
Orlistat—PLA2G4A—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000435	0.00215	CbGpPWpGaD
Orlistat—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000433	0.00214	CbGpPWpGaD
Orlistat—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000433	0.00105	CcSEcCtD
Orlistat—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000433	0.00105	CcSEcCtD
Orlistat—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000424	0.00102	CcSEcCtD
Orlistat—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000423	0.00102	CcSEcCtD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.00042	0.00208	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000419	0.00207	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000419	0.00207	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	0.000419	0.00207	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000419	0.00207	CbGpPWpGaD
Orlistat—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000417	0.00206	CbGpPWpGaD
Orlistat—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000416	0.001	CcSEcCtD
Orlistat—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000416	0.001	CcSEcCtD
Orlistat—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000413	0.000997	CcSEcCtD
Orlistat—Rash—Formoterol—chronic obstructive pulmonary disease	0.000413	0.000997	CcSEcCtD
Orlistat—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000412	0.000996	CcSEcCtD
Orlistat—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000412	0.000996	CcSEcCtD
Orlistat—FASN—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000411	0.00203	CbGpPWpGaD
Orlistat—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00041	0.00099	CcSEcCtD
Orlistat—Headache—Formoterol—chronic obstructive pulmonary disease	0.00041	0.00099	CcSEcCtD
Orlistat—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000409	0.000988	CcSEcCtD
Orlistat—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000409	0.000987	CcSEcCtD
Orlistat—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000408	0.000984	CcSEcCtD
Orlistat—FASN—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000408	0.00201	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet homeostasis—NOS3—chronic obstructive pulmonary disease	0.000405	0.002	CbGpPWpGaD
Orlistat—Rash—Montelukast—chronic obstructive pulmonary disease	0.000404	0.000976	CcSEcCtD
Orlistat—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000404	0.000975	CcSEcCtD
Orlistat—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000403	0.000973	CcSEcCtD
Orlistat—Depression—Prednisone—chronic obstructive pulmonary disease	0.000403	0.000972	CcSEcCtD
Orlistat—Headache—Montelukast—chronic obstructive pulmonary disease	0.000402	0.00097	CcSEcCtD
Orlistat—FASN—Metabolism—GC—chronic obstructive pulmonary disease	0.0004	0.00198	CbGpPWpGaD
Orlistat—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000397	0.000958	CcSEcCtD
Orlistat—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000396	0.000956	CcSEcCtD
Orlistat—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.000949	CcSEcCtD
Orlistat—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000392	0.000946	CcSEcCtD
Orlistat—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00039	0.000942	CcSEcCtD
Orlistat—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00039	0.00193	CbGpPWpGaD
Orlistat—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00039	0.000941	CcSEcCtD
Orlistat—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000389	0.00094	CcSEcCtD
Orlistat—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000389	0.000939	CcSEcCtD
Orlistat—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000389	0.000939	CcSEcCtD
Orlistat—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000387	0.000935	CcSEcCtD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000385	0.0019	CbGpPWpGaD
Orlistat—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000381	0.00092	CcSEcCtD
Orlistat—DAGLB—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.00038	0.00188	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.00038	0.00188	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000378	0.00187	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000378	0.00187	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000377	0.00186	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000377	0.00186	CbGpPWpGaD
Orlistat—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000376	0.000909	CcSEcCtD
Orlistat—DAGLA—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000374	0.00185	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000374	0.00185	CbGpPWpGaD
Orlistat—FASN—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000372	0.00184	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—MMP9—chronic obstructive pulmonary disease	0.000371	0.00184	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000368	0.00182	CbGpPWpGaD
Orlistat—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000367	0.000887	CcSEcCtD
Orlistat—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000365	0.000882	CcSEcCtD
Orlistat—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000365	0.00088	CcSEcCtD
Orlistat—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000363	0.000876	CcSEcCtD
Orlistat—DAGLA—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000361	0.00178	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000361	0.00178	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000358	0.00177	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000358	0.00177	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.000357	0.00176	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.000357	0.00176	CbGpPWpGaD
Orlistat—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000355	0.000856	CcSEcCtD
Orlistat—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000355	0.000856	CcSEcCtD
Orlistat—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000343	0.000828	CcSEcCtD
Orlistat—DAGLB—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.00034	0.00168	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.00034	0.00168	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	0.000332	0.00164	CbGpPWpGaD
Orlistat—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000328	0.000791	CcSEcCtD
Orlistat—DAGLB—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000327	0.00162	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000327	0.00162	CbGpPWpGaD
Orlistat—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000321	0.000774	CcSEcCtD
Orlistat—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000321	0.000774	CcSEcCtD
Orlistat—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000318	0.000769	CcSEcCtD
Orlistat—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000318	0.000767	CcSEcCtD
Orlistat—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000316	0.000762	CcSEcCtD
Orlistat—PNLIP—Disease—HDAC2—chronic obstructive pulmonary disease	0.00031	0.00153	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000309	0.00153	CbGpPWpGaD
Orlistat—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000306	0.00151	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000305	0.00151	CbGpPWpGaD
Orlistat—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000303	0.000732	CcSEcCtD
Orlistat—PLA2G4A—AGE/RAGE pathway—EGFR—chronic obstructive pulmonary disease	0.0003	0.00148	CbGpPWpGaD
Orlistat—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000298	0.000718	CcSEcCtD
Orlistat—DAGLB—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000297	0.00147	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000297	0.00147	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000297	0.00147	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000296	0.00146	CbGpPWpGaD
Orlistat—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000293	0.000707	CcSEcCtD
Orlistat—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000292	0.000705	CcSEcCtD
Orlistat—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000288	0.000696	CcSEcCtD
Orlistat—PNLIP—Disease—KL—chronic obstructive pulmonary disease	0.000288	0.00142	CbGpPWpGaD
Orlistat—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000285	0.000687	CcSEcCtD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000285	0.00141	CbGpPWpGaD
Orlistat—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000284	0.000685	CcSEcCtD
Orlistat—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000282	0.00068	CcSEcCtD
Orlistat—PNLIP—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000278	0.00138	CbGpPWpGaD
Orlistat—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000274	0.00066	CcSEcCtD
Orlistat—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000269	0.000649	CcSEcCtD
Orlistat—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000268	0.000647	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000267	0.000644	CcSEcCtD
Orlistat—PLA2G4A—Metabolism—APIP—chronic obstructive pulmonary disease	0.000266	0.00132	CbGpPWpGaD
Orlistat—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000266	0.000641	CcSEcCtD
Orlistat—DAGLB—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000262	0.00129	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000262	0.00129	CbGpPWpGaD
Orlistat—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000261	0.000631	CcSEcCtD
Orlistat—DAGLB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.00026	0.00128	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.00026	0.00128	CbGpPWpGaD
Orlistat—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000258	0.000622	CcSEcCtD
Orlistat—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000258	0.000622	CcSEcCtD
Orlistat—PNLIP—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000257	0.00127	CbGpPWpGaD
Orlistat—Infection—Prednisone—chronic obstructive pulmonary disease	0.000256	0.000618	CcSEcCtD
Orlistat—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000253	0.00125	CbGpPWpGaD
Orlistat—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000253	0.00061	CcSEcCtD
Orlistat—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00025	0.000604	CcSEcCtD
Orlistat—PLA2G4A—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.00025	0.00124	CbGpPWpGaD
Orlistat—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000249	0.000601	CcSEcCtD
Orlistat—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000248	0.00122	CbGpPWpGaD
Orlistat—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000244	0.00121	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000243	0.0012	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000243	0.0012	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000243	0.0012	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000239	0.00118	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000239	0.00118	CbGpPWpGaD
Orlistat—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000235	0.000567	CcSEcCtD
Orlistat—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000234	0.000566	CcSEcCtD
Orlistat—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000233	0.000563	CcSEcCtD
Orlistat—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000231	0.000559	CcSEcCtD
Orlistat—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000227	0.000548	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000225	0.00111	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000225	0.00111	CbGpPWpGaD
Orlistat—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000224	0.000541	CcSEcCtD
Orlistat—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000224	0.00054	CcSEcCtD
Orlistat—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000223	0.000539	CcSEcCtD
Orlistat—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000223	0.0011	CbGpPWpGaD
Orlistat—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000222	0.000536	CcSEcCtD
Orlistat—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000222	0.000536	CcSEcCtD
Orlistat—FASN—Disease—HDAC2—chronic obstructive pulmonary disease	0.000219	0.00108	CbGpPWpGaD
Orlistat—FASN—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000218	0.00108	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000217	0.00107	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000217	0.00107	CbGpPWpGaD
Orlistat—PNLIP—Disease—ERBB3—chronic obstructive pulmonary disease	0.000216	0.00107	CbGpPWpGaD
Orlistat—FASN—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000216	0.00107	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000214	0.00106	CbGpPWpGaD
Orlistat—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000212	0.000513	CcSEcCtD
Orlistat—PNLIP—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000211	0.00104	CbGpPWpGaD
Orlistat—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000211	0.000509	CcSEcCtD
Orlistat—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000211	0.000508	CcSEcCtD
Orlistat—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000205	0.000494	CcSEcCtD
Orlistat—FASN—Disease—KL—chronic obstructive pulmonary disease	0.000204	0.00101	CbGpPWpGaD
Orlistat—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000204	0.000492	CcSEcCtD
Orlistat—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000204	0.000492	CcSEcCtD
Orlistat—DAGLA—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000202	0.001	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000202	0.001	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000202	0.000997	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000201	0.000995	CbGpPWpGaD
Orlistat—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000201	0.000993	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000201	0.000992	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000201	0.000992	CbGpPWpGaD
Orlistat—FASN—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000197	0.000974	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000197	0.000972	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—TP53—chronic obstructive pulmonary disease	0.000196	0.000971	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—TP53—chronic obstructive pulmonary disease	0.000196	0.000971	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000194	0.00096	CbGpPWpGaD
Orlistat—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00019	0.000458	CcSEcCtD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.00019	0.000938	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000189	0.000935	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000186	0.000921	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000186	0.00092	CbGpPWpGaD
Orlistat—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000185	0.000446	CcSEcCtD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.000184	0.000912	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.000184	0.00091	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000184	0.000908	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000184	0.000908	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000182	0.000902	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000182	0.000902	CbGpPWpGaD
Orlistat—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000182	0.00044	CcSEcCtD
Orlistat—FASN—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000182	0.000897	CbGpPWpGaD
Orlistat—PNLIP—Disease—NOS2—chronic obstructive pulmonary disease	0.00018	0.00089	CbGpPWpGaD
Orlistat—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00018	0.00089	CbGpPWpGaD
Orlistat—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000178	0.000878	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000176	0.000872	CbGpPWpGaD
Orlistat—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000426	CcSEcCtD
Orlistat—DAGLB—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000176	0.000868	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000176	0.000868	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000175	0.000866	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000175	0.000865	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GC—chronic obstructive pulmonary disease	0.000172	0.000848	CbGpPWpGaD
Orlistat—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000411	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000166	0.000822	CbGpPWpGaD
Orlistat—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000395	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000163	0.000807	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000163	0.000807	CbGpPWpGaD
Orlistat—Rash—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000392	CcSEcCtD
Orlistat—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000392	CcSEcCtD
Orlistat—Headache—Prednisone—chronic obstructive pulmonary disease	0.000161	0.00039	CcSEcCtD
Orlistat—PLA2G4A—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00016	0.000788	CbGpPWpGaD
Orlistat—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000369	CcSEcCtD
Orlistat—FASN—Disease—ERBB3—chronic obstructive pulmonary disease	0.000153	0.000755	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000153	0.000754	CbGpPWpGaD
Orlistat—PNLIP—Disease—SERPINE1—chronic obstructive pulmonary disease	0.000152	0.000749	CbGpPWpGaD
Orlistat—FASN—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000151	0.000748	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000151	0.000747	CbGpPWpGaD
Orlistat—FASN—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000149	0.000738	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000147	0.000729	CbGpPWpGaD
Orlistat—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000146	0.000721	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000146	0.000719	CbGpPWpGaD
Orlistat—PNLIP—Disease—NOS3—chronic obstructive pulmonary disease	0.000145	0.000715	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000143	0.000705	CbGpPWpGaD
Orlistat—FASN—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000139	0.000688	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000135	0.000669	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000134	0.000664	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000134	0.000664	CbGpPWpGaD
Orlistat—FASN—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000132	0.000652	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000131	0.000647	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000128	0.000634	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000128	0.000634	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000128	0.000633	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000128	0.000633	CbGpPWpGaD
Orlistat—FASN—Disease—NOS2—chronic obstructive pulmonary disease	0.000127	0.00063	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000127	0.000628	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000127	0.000627	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000127	0.000627	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—ALB—chronic obstructive pulmonary disease	0.000127	0.000626	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000125	0.000619	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000123	0.000607	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000122	0.000605	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000122	0.000605	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000122	0.000604	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000121	0.000599	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000116	0.000576	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000113	0.000558	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000112	0.000552	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000108	0.000536	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000108	0.000536	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000108	0.000532	CbGpPWpGaD
Orlistat—FASN—Disease—SERPINE1—chronic obstructive pulmonary disease	0.000107	0.00053	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000107	0.000527	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000106	0.000525	CbGpPWpGaD
Orlistat—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000105	0.00052	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000103	0.00051	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000103	0.00051	CbGpPWpGaD
Orlistat—FASN—Disease—NOS3—chronic obstructive pulmonary disease	0.000102	0.000506	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000101	0.000501	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.81e-05	0.000485	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.81e-05	0.000485	CbGpPWpGaD
Orlistat—PNLIP—Disease—TGFB1—chronic obstructive pulmonary disease	9.57e-05	0.000473	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	9.57e-05	0.000473	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	9.51e-05	0.00047	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—ALB—chronic obstructive pulmonary disease	9.49e-05	0.000469	CbGpPWpGaD
Orlistat—PNLIP—Disease—EGFR—chronic obstructive pulmonary disease	9.38e-05	0.000464	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.37e-05	0.000463	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GCLC—chronic obstructive pulmonary disease	9.27e-05	0.000458	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—NOS3—chronic obstructive pulmonary disease	9.08e-05	0.000449	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	9.01e-05	0.000445	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.99e-05	0.000444	CbGpPWpGaD
Orlistat—FASN—Metabolism—ALB—chronic obstructive pulmonary disease	8.97e-05	0.000443	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.9e-05	0.00044	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.81e-05	0.000436	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.81e-05	0.000436	CbGpPWpGaD
Orlistat—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.77e-05	0.000434	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.64e-05	0.000427	CbGpPWpGaD
Orlistat—FASN—Metabolism—NOS3—chronic obstructive pulmonary disease	8.58e-05	0.000424	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	8.55e-05	0.000423	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CTGF—chronic obstructive pulmonary disease	8.45e-05	0.000418	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.18e-05	0.000404	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.13e-05	0.000402	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.09e-05	0.0004	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.09e-05	0.0004	CbGpPWpGaD
Orlistat—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.06e-05	0.000399	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.93e-05	0.000392	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.93e-05	0.000392	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.79e-05	0.000385	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.75e-05	0.000383	CbGpPWpGaD
Orlistat—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.64e-05	0.000378	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	7.48e-05	0.00037	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.3e-05	0.000361	CbGpPWpGaD
Orlistat—PNLIP—Disease—IL6—chronic obstructive pulmonary disease	7.21e-05	0.000356	CbGpPWpGaD
Orlistat—FASN—Disease—TGFB1—chronic obstructive pulmonary disease	6.77e-05	0.000335	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.7e-05	0.000331	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.66e-05	0.000329	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.66e-05	0.000329	CbGpPWpGaD
Orlistat—FASN—Disease—EGFR—chronic obstructive pulmonary disease	6.64e-05	0.000328	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.59e-05	0.000326	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.57e-05	0.000325	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	6.54e-05	0.000323	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.5e-05	0.000321	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.41e-05	0.000317	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	6.24e-05	0.000308	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.12e-05	0.000303	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.09e-05	0.000301	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.09e-05	0.000301	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	6e-05	0.000297	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.97e-05	0.000295	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.66e-05	0.00028	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.65e-05	0.000279	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.52e-05	0.000273	CbGpPWpGaD
Orlistat—FASN—Disease—IL6—chronic obstructive pulmonary disease	5.1e-05	0.000252	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.05e-05	0.00025	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.05e-05	0.00025	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TP53—chronic obstructive pulmonary disease	4.94e-05	0.000244	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.62e-05	0.000228	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.59e-05	0.000227	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.42e-05	0.000218	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.13e-05	0.000204	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.11e-05	0.000203	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	4.02e-05	0.000199	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ALB—chronic obstructive pulmonary disease	3.85e-05	0.00019	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.74e-05	0.000185	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—NOS3—chronic obstructive pulmonary disease	3.68e-05	0.000182	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.38e-05	0.000167	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.22e-05	0.000159	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.08e-05	0.000152	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.73e-05	0.000135	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.6e-05	0.000128	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.47e-05	0.000122	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.22e-05	0.00011	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.2e-05	0.000109	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.17e-05	0.000107	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.03e-05	0.000101	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2e-05	9.86e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.98e-05	9.79e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.82e-05	9.02e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.68e-05	8.28e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.53e-05	7.58e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.52e-05	7.52e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.5e-05	7.42e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.4e-05	6.91e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.33e-05	6.55e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	9.01e-06	4.45e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	8.62e-06	4.26e-05	CbGpPWpGaD
